Literature DB >> 17034669

Difficult pain syndromes: bone pain, visceral pain, and neuropathic pain.

Lauren Shaiova1.   

Abstract

Cancer pain is prevalent in approximately two thirds of all cancer patients and can undermine the quality of life in this patient population. Uncontrolled pain can cause physical as well as psychological distress in cancer patients. As the disease progresses in cancer, pain and suffering increase. Knowledge about pain management is paramount in the comprehensive treatment of cancer patients. Difficult cancer pain syndromes may arise from interruption of bone, viscera, and neural structures by malignant spread of the disease. Familiarity with opioids, adjuvants, and procedures that can abate pain in cancer patients is discussed in a practical manner for clinical application in this text.

Entities:  

Mesh:

Year:  2006        PMID: 17034669     DOI: 10.1097/00130404-200609000-00002

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  5 in total

1.  Chemotherapy-Induced Peripheral Neuropathy in Pediatric Cancer Patients.

Authors:  Rhonda J Moore; Hunter Groninger
Journal:  Cureus       Date:  2013-06-14

2.  Pain, neuropathic symptoms, and physical and mental well-being in persons with cancer.

Authors:  Cindy S Tofthagen; Susan C McMillan
Journal:  Cancer Nurs       Date:  2010 Nov-Dec       Impact factor: 2.592

3.  Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat.

Authors:  Elizabeth K Joseph; Jon D Levine
Journal:  J Pain       Date:  2009-02-23       Impact factor: 5.820

4.  Characteristics and prognostic factors for pain management in 152 patients with lung cancer.

Authors:  Lei Shi; Yumei Liu; Hua He; Cong Wang; Hongwei Li; Nanya Wang
Journal:  Patient Prefer Adherence       Date:  2016-04-15       Impact factor: 2.711

Review 5.  Cancer Pain Management: Comprehensive Assessment and Nonopioid Analgesics, Part 1.

Authors:  Rita J Wickham
Journal:  J Adv Pract Oncol       Date:  2017-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.